SNDX icon

Syndax Pharmaceuticals

121 hedge funds and large institutions have $1.02B invested in Syndax Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 48 increasing their positions, 36 reducing their positions, and 24 closing their positions.

Holders
121
Holders Change
-15
Holders Change %
-11.03%
% of All Funds
2.05%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
13
Increased
48
Reduced
36
Closed
24
Calls
$3.85M
Puts
$381K
Net Calls
+$3.46M
Net Calls Change
+$1.93M
Name Market Value Shares Shares
Change
Shares
Change %
APM
1
Avidity Partners Management
Texas
$105M 5,450,000 +626,600 +13%
BlackRock
2
BlackRock
New York
$73M 3,795,909 -2,241 -0.1%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$61.7M 3,206,866 +1,372,936 +75%
FLSM
4
Frazier Life Sciences Management
California
$61.5M 3,195,403
Vanguard Group
5
Vanguard Group
Pennsylvania
$53.5M 2,780,903 +348,465 +14%
NCM
6
Nantahala Capital Management
Connecticut
$51.2M 2,663,087 -29,216 -1%
KCM
7
Kynam Capital Management
New Jersey
$48.3M 2,512,240 +579,440 +30%
State Street
8
State Street
Massachusetts
$46.9M 2,435,517 +55,180 +2%
BI
9
BVF Inc
California
$45.3M 2,356,934 -37,780 -2%
ACA
10
Avoro Capital Advisors
New York
$42.8M 2,222,222 +1,722 +0.1%
Citadel Advisors
11
Citadel Advisors
Florida
$33.3M 1,729,052 -96,388 -5%
6CM
12
683 Capital Management
New York
$30.4M 1,581,653
Adage Capital Partners
13
Adage Capital Partners
Massachusetts
$23.8M 1,237,300 +158,659 +15%
SFM
14
Sphera Funds Management
Israel
$21.9M 1,139,329 -138,084 -11%
DM
15
Deerfield Management
New York
$21.4M 1,111,111 +1,111,111 New
ACM
16
Aisling Capital Management
New York
$19.7M 1,025,000
EP
17
Eversept Partners
New York
$19.1M 994,362 +994,362 New
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$18.5M 961,106 +76,772 +9%
HM
19
HealthCor Management
New York
$17.8M 923,400 -257,100 -22%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$17.5M 907,856 +52,441 +6%
PBA
21
Paradigm Biocapital Advisors
New York
$16.9M 876,156 +174,800 +25%
PAI
22
Palo Alto Investors
California
$11.8M 612,600
JPMorgan Chase & Co
23
JPMorgan Chase & Co
New York
$11.4M 594,302 +354,473 +148%
PHS
24
PFM Health Sciences
California
$11.2M 580,768 -1,462,609 -72%
Goldman Sachs
25
Goldman Sachs
New York
$10.5M 546,239 +137,976 +34%